Value through Innovation

main navigation

jump to content to meta navigation
Headillu

page content

jump to main navigation to meta navigation

Boehringer Ingelheim Press Releases

See the latest Boehringer Ingelheim news releases. To quickly find all news releases on a specific topic, please use the fulltext search.

Press Release Archive

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
25.04.2008 Data suggests promising overall survival and progression-free survival with Vargatef™ (BIBF 1120) - For medical media, outside the US only
17.04.2008 New data confirm pramipexole (Mirapexin®/Sifrol®) can significantly reduce sleep disturbance for people with Restless Legs Syndrome (RLS) - For medical media, outside the US only
17.04.2008 First ever European Porcine-Circovirus-Research-Award Winners honoured
14.04.2008 New powerful antihypertensive MicardisPlus® 80/25 (80mg telmisartan/25mg hydrochlorothiazide) approved by EU Commission
08.04.2008 Boehringer Ingelheim outpaces the market yet again in 2007
Spiriva®, Micardis® and Flomax® are the major products
A host of compounds in the pipeline from own research and development
31.03.2008 Landmark trial ONTARGET proves telmisartan is as protective as ramipril and better tolerated in a broad high-risk cardiovascular population.
From ONTARGET® it may be concluded that telmisartan can prevent every 5th serious cardiovascular event. - For medical media, outside the US only
27.03.2008 Novel oral anticoagulant Pradaxa® (dabigatran etexilate) approved by the European Commission - For medical media, outside the US only
14.02.2008 FDA grants fast track designation for Boehringer Ingelheim’s BIBW 2992 for the treatment of late stage non small cell lung cancer (NSCLC) - For medical media, outside the US only
12.02.2008 Boehringer Ingelheim initiates new HIV/AIDS Trial for extended release formulation of Viramune® - For medical media, outside the US only
25.01.2008 European Medicines Agency recommends approval of novel oral anticoagulant, dabigatran etexilate (Pradaxa®) - For medical media, outside the US only
17.01.2008 Boehringer Ingelheim announces enrolment completion of the largest atrial fibrillation outcomes trial – The RE-LY™ Study - For medical media, outside the US only
28.12.2007 Publication of the INSPIRE study results
11.12.2007 Pramipexole monotherapy can reduce dyskinesias and delay the need for levodopa treatment in patients with Parkinson`s disease - For medical media, outside the US only
09.12.2007 Boehringer Ingelheim announces study in ACS patients with novel oral direct thrombin inhibitor dabigatran etexilate - For medical media, outside the US only
29.11.2007 "Biotechnology made in Biberach": Expansion of biopharmaceutical production plant further strengthens Boehringer Ingelheim’s expertise in biotechnology
20.11.2007 Biopharmaceuticals in prefilled syringes complement Boehringer Ingelheim’s contract manufacturing services
14.11.2007 International communication award recognises and rewards journalism that extends public awareness and understanding of COPD
26.10.2007 Heinrich Wieland Prize 2007 awarded to Joachim Herz for uncovering novel functions for lipoprotein receptors
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
back to top

Contact

Boehringer Ingelheim GmbH

Corporate Headquarters
Binger Str. 173
55216 Ingelheim
Germany


Phone +49 / 6132 / 77 0
Fax +49 / 6132 / 72 0

media contacts

RSS feeds allow you to receive latest news and information about Boehringer Ingelheim.

subscribe to RSS Feed